Erica Harris

Erica Harris, LT, serves as a contracting officer at the Naval Medical Research Center (N32398), where she plays a critical role in advancing the Department of the Navy’s force health protection mission through the acquisition of specialized biomedical technologies. She manages a portfolio of research and development contracts focused on field-deployable diagnostics, infectious disease detection systems, and laboratory analytical tools designed for austere operational environments. Her acquisitions support the center’s strategic priorities in rapid pathogen identification, precision monitoring, and translational medical innovation, ensuring Navy and Marine Corps personnel have access to cutting-edge medical capabilities in expeditionary settings. LT Harris maintains a consistent working relationship with REES SCIENTIFIC CORPORATION, a key contractor providing advanced diagnostic instrumentation and biomedical research support services. Her procurement patterns reflect a preference for established technical partners with proven expertise in laboratory-grade medical device development and field-validation of diagnostic platforms. She engages with vendors capable of meeting stringent military specifications for reliability, portability, and environmental resilience, often requiring compliance with DoD standards for biocompatibility and data security. Her contracting portfolio is entirely non-set-aside, with 100% of awards issued under full and open competition, reflecting a mission-driven emphasis on technical capability over socioeconomic preferences. This approach underscores her focus on acquiring the most effective solutions available, regardless of vendor size or certification status, while still adhering to all federal acquisition regulations. LT Harris specializes in procurements aligned with biomedical research, diagnostic equipment, and laboratory automation systems, with a technical focus on infectious disease surveillance, point-of-care testing, and deployable analytical platforms. Her expertise lies in evaluating complex scientific proposals, ensuring technical feasibility, and managing contract performance for high-stakes medical R&D initiatives critical to operational readiness.